Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Tirzepatide's SURMOUNT-1 trial [1] included 17% of participants over age 65, who experienced 18.4% weight loss compared to 20.1% in younger adults
This interaction extends beyond glucose regulation and may provide novel therapeutic targets for metabolic and inflammatory diseases
Use and Efficacy : Despite strong anecdotal support, there is a lack of rigorous human studies to confirm its effectiveness
Devon M
US$ 27.85
US$ 25.98
US$ 29.05
US$ 25.67
US$ 28.65
US$ 24.12
US$ 28.64
US$ 26.28
